Меню
Идёт набор NCT06920979

Stop Sepsis Through Home Monitoring Cooperative

Без фазы С лечением Sepsis Home Monitoring Follow-up Infection Innovativeness

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: (semi)continue monitoring of patients at risk for sepsis at home.
Кому может быть актуально
Состояния в реестре: Sepsis, Home Monitoring Follow-up, Infection, Innovativeness. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Бельгия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

In this study, patients presenting with acute infections at risk of developing sepsis will be followed in their home setting using wearables that provide (semi-)continue monitoring of vital signs as well as through follow up using a designated smartphone application. This is an innovative pilot study that will examine the potential of transmural care through telemonitoring for the first time in patients at risk for developing sepsis. By allowing for active follow-up of vital parameters in a transmural setting, this project aims to reduce the number of hospitalizations as compared to current practice. Furthermore, we aim to the number of patients referred to the emergency department after a visit at their primary care physician. Thereby, we aim to reduce the healthcare burden, yet providing the ability for rapid intervention in case of detarioration of patients, thereby reducing morbidity and mortality as well as associated costs.

Вмешательства

  • Другое (semi)continue monitoring of patients at risk for sepsis at home
    (semi)continue monitoring of patients at risk for sepsis at home

Первичные конечные точки

  • Evaluation of the development and roll out of a central medical center for monitoring at home [Срок оценки: From enrollment to the end of monitoring depending on the clinical evolution of the patient, with a minimum of one week and a maximum follow-up of three weeks.]
  • Evaluation of the development and roll out of a central medical center for monitoring at home [Срок оценки: From enrollment to the end of monitoring depending on the clinical evolution of the patient with a minimum follow-up of one week and up to a maximum of three weeks.]
  • Evaluation of the development and roll out of a central medical center for monitoring at home [Срок оценки: From enrollment to the end of monitoring depending on the clinical evolution of the patient with a minimum follow-up of one week and up to a maximum of three weeks of follow-up.]
  • Evaluation of the development and roll out of a central medical center for monitoring at home [Срок оценки: From enrollment to the end of monitoring depending on the clinical evolution of the patient with a minimum follow-up of one week and up to a maximum of three weeks of follow-up.]

Критерии участия

Критерии включения

  • This study will include patients aged 18 years or older, capable of giving informed consent, presenting with signs of severe acute infection with a risk of developing sepsis at the emergency department or at their primary care physician.

Критерии исключения

  • Patients that are severely ill and require immediate hospitalization Qucik Sepsis Related Organ Failure score (QSOFA) ≥ 1 National Early Warning Score (NEWS) ≥ 5
  • Patients that demonstrate confusion, changes in mental state and/or an Mini-Mental State Examination (MMSE) below 26
  • Presence of neuropenic fever
  • Patients currently undergoing immunosuppressive therapy or chemotherapy
  • Patients with human immunodeficiency virus (HIV) or Acquired Immune Deficiency Syndrome (AIDS)
  • Suspicion of appendicitis, suspicion of meningitis or meningeal irritation, suspicion of or high risk of developing endocarditis
  • Complicated operation wounds at the time of screening
  • Proven pneumonia (CURB 65 score ≥ 1)
  • Emphysema, Chronic Obstructive Pulmonary Disease (COPD) GOLD >1 or interstitial lung disease
  • Patients with oxygen at home > 2 l/min on a chronic basis (severe underlying lung disease?)
  • Severe cardiovascular disease including:
  • Severe heart failure New York Heart Association (NYHA) class > 1
  • Endoprosthesis
  • Cardiac arrhythmia including atrial fibrillation
  • Severe heart valve abnormalities
  • Mechanic valve replacement
  • Recent acute myocardial infarct or coronarography (less than 1y ago)
  • Severe peripheral vascular morbidity
  • Acute chest pain (suspicion of acute coronary pathology)
  • Suspicion of/chance of septic arthritis

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Поддерживающая терапия

Центры проведения

Бельгия · 1 центр
  • Antwerp University Hospital (UZA) — Edegem

Идентификаторы

NCT: NCT06920979 · EDGE003963 · Governement Health Belgium

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗